Company intelligence
Gero
AI-driven drug discovery company focused on therapies targeting age-related diseases
Biotechnology
Palo Alto, US
139 employees
Founded 2018
3 public signals
About Gero
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
Verified activity
Signals from Gero
3 published signals
Presence & Recognition
Gero employee Anton Malyshev attended the TechBBQ event in Copenhagen.
Reported by Anton Malyshev
People
Gero appointed Amir Feizi as Head of Tranlational AI and Target Discovery in Basel
Reported by Gero
Presence & Recognition
Gero will speak at the Drug Discovery Innovation Programme (DDIP) in Basel later this month, sharing work on AI-driven target discovery using human genetics and longitudinal health data.
Reported by Amir Feizi